National HealthCare Corporation (NHC) Stock Forecasts

NATIONAL HEALTHCARE CORP (NHC) filed an SEC Form 8-K — Results of Operations and Financial Condition. Exhibit 99.1 For release: August 7, 2026 Contact: Brian F. Kidd, SVP/CFO Phone: (615) 890-2020 NHC Reports Second Quarter 2026 Earnings MURFREESBORO, Tenn. -- National HealthCare Corporation (NYSE American: NHC), the nation's oldest publicly traded senior health care company, ann

NATIONAL HEALTHCARE CORP (NHC) filed an SEC Form 8-K — Completion of Acquisition or Disposition of Assets. EX-10.2 3 ex_983366.htm EXHIBIT 10.2 ex_983366.htm Exhibit 10.2 PARTIAL MASTER LEASE TERMINATION AGREEMENT AND PARTIAL ASSIGNMENT AND ASSUMPTION OF MASTER LEASE This Partial Master Lease Termination Agreement and Partial Assignment and Assumption of Master Lease (this “ Agreement

Australian coal stocks rose sharply after a deadly explosion at China’s Liushenyu mine in Shanxi raised concerns about tighter coking coal supply. Whitehaven Coal gained 8.7%, Yancoal 7.5% and New Hope 4.7%, outpacing the ASX 200, as Chinese coking coal futures jumped nearly 8% to their limit. The accident killed at least 82 miners, and China ordered a safety investigation.

Genmab (GMAB) reported positive Phase 3 trial results for Petosemtamab combined with Keytruda in head and neck cancer, showing a 50% reduction in death risk and improved tumor response. The combination met primary endpoints and was well tolerated. GMAB plans regulatory discussions and further trials. The stock is up 28.89% at $57.53.

Visteon Corp (VC) shares fell 4% after announcing CFO Jerome Rouquet will depart by November 30, 2026. Colleen Myers, current VP and Chief Accounting Officer, will serve as interim CFO. The company is searching for a permanent successor. Rouquet has been with Visteon for six years. CEO Sachin Lawande expressed confidence in Myers' leadership during the transition.

UBS analysts rank nitrogen fertilizer producers favorably for 2027, citing demand and supply challenges. CF Industries (CF) is seen as the top beneficiary, with estimates raised. Nutrien (NTR) and Mosaic (MOS) are also analyzed, with mixed outlooks. UBS expects higher pricing into spring, despite concerns like Chinese exports and ammonia markets.